Efficacy and safety of tacrolimus 0.1% for the treatment of facial vitiligo: a multicenter randomized, double-blinded, vehicle-controlled study.
暂无分享,去创建一个
H. Maillard | R. Lassalle | A. Taïeb | K. Ezzedine | J. Seneschal | T. Passeron | C. Droitcourt | Alexandra Duplaine | N. Andreu | C. Favary